• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Virtual reality software COPD
medicalpneumologytraining

virtual reality software
virtual reality software
virtual reality software
Add to favorites
Compare this product
 

Characteristics

Applications
medical, pneumology
Function
training, simulation
Type
virtual reality
Other characteristics
for pneumonia, for COPD

Description

Assess a patient with a COPD exacerbation, apply evidence-based interventions, communicate using SBAR, and provide therapeutic communication and education to patients and families. Learning Objectives Conduct a focused nursing assessment of a patient with a COPD exacerbation Implement evidence-based nursing interventions for a patient with a COPD exacerbation Communicate the patient's condition to the provider using SBAR Provide therapeutic communication and education to the patient and family Customization Examples Any UbiSim scenario can be customized with UbiSim's Intuitive Editor. Possible customization examples for this scenario include: COPD + pneumonia > antibiotics + routine medication Adult asthma exacerbation Pneumonia + respiratory distress Influenza + respiratory distress Customize Scenarios or Create Your Own with UbiSim’s Intuitive Editor UbiSim is the only VR nursing platform with an intuitive editor. Nurse educators and simulationists can personally customize UbiSim’s existing peer-reviewed scenarios however they like, create their own immersive VR simulations from scratch, or even use scenarios shared by other nursing programs within our UbiSim Community. Edit UbiSim’s pre-made scenarios to fit your unique needs Create your own immersive VR simulations Share, edit and re-use custom scenarios with fellow educators in the UbiSim Community

Other UbiSim products

scenarios

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.